KR910009328B1 - Process for preparation of 2-furylpurine derivatives - Google Patents

Process for preparation of 2-furylpurine derivatives Download PDF

Info

Publication number
KR910009328B1
KR910009328B1 KR1019890020246A KR890020246A KR910009328B1 KR 910009328 B1 KR910009328 B1 KR 910009328B1 KR 1019890020246 A KR1019890020246 A KR 1019890020246A KR 890020246 A KR890020246 A KR 890020246A KR 910009328 B1 KR910009328 B1 KR 910009328B1
Authority
KR
South Korea
Prior art keywords
formula
furylpurine
mmol
amine
cesium chloride
Prior art date
Application number
KR1019890020246A
Other languages
Korean (ko)
Other versions
KR910011857A (en
Inventor
김용해
이춘호
Original Assignee
한국과학기술원
이상수
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국과학기술원, 이상수 filed Critical 한국과학기술원
Priority to KR1019890020246A priority Critical patent/KR910009328B1/en
Publication of KR910011857A publication Critical patent/KR910011857A/en
Application granted granted Critical
Publication of KR910009328B1 publication Critical patent/KR910009328B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A process for preparing 2-furylpurine of formula (I) comprises (a) reacting a purine cpd. of formula (II) with a silylating agent (pref. hexamethyl silazane) to obtain trimethylsilyl cpd., and (b) reacting the obtd. cpd. with 2- acetoxy tetrahydrofurane of formula (III) in an organic solvent (pref. acetonitrile) in the presence of cesium chloride. In the formulas, X = H, NH2 or SH; Y = NH2, Cl, SMe or OH; pref. when X = H, Y = NH2, Cl, SMe or OH; when X = NH2, Y = NH2 or OH; when X = SH, Y = NH2. Cpds. (I) have a antitumor activity.

Description

2-푸릴퓨린 유도체의 제조방법Method for preparing 2-furylpurine derivative

본 발명은 일반식(I)로 표시되는 2-푸릴퓨린의 새롭고도 진보된 제조방법에 관한 것으로 이들은 항종양작용을 나타내는 유기화합물이거나 이와 관련된 중요한 유기화합물이다.The present invention relates to a new and advanced process for preparing 2-furylpurine represented by general formula (I), which is an organic compound exhibiting antitumor action or an important organic compound related thereto.

Figure kpo00001
Figure kpo00001

일반식(I)에 있어서, X는 수소(-H), 아민(-NH2) 또는 티올(-SH)기이고; Y는 아민(-NH2), 염소(-Cl), 메틸티오(-SMe) 또는 수산기(-OH)이다. 바람직하게는, X가 수소인 경우, Y는 아민, 염소, 메틸티오 또는 수산기이고; X가 아민인 경우, Y는 아민 또는 수산기이며; X가 티올인 경우 Y는 아민이다.In formula (I), X is hydrogen (-H), amine (-NH 2 ) or thiol (-SH) group; Y is an amine (-NH 2 ), chlorine (-Cl), methylthio (-SMe) or hydroxyl group (-OH). Preferably, when X is hydrogen, Y is an amine, chlorine, methylthio or hydroxyl group; When X is an amine, Y is an amine or hydroxyl group; Y is an amine when X is a thiol.

일반식(I)의 퓨린 유도체의 공지 제조방법은 여러 문헌에 소개되고 있는 바, 대표적인 것을 인용하면 다음과 같다.Known preparation methods for the purine derivatives of general formula (I) have been introduced in various literatures.

[산 촉매를 사용하는 방법.][Method of using acid catalyst.]

6-벤질옥시퓨린을 p-TsOH 산 촉매를 사용하여 2,3-디히드로푸란과 반응시켜 결합시킨 후 Pd-C 촉매하에서 벤질기를 제거하여 9-(테트라히드로-2-푸릴) 히포잔틴을 얻고 있다. 그러나 이와 같은 방법은 퓨린 염기의 -OH나 -NH 등이 있는 경우 곧바로 사용될 수 없으므로 공정 단계가 많게 되고 따라서 수율도 낮은 것으로 보고되고 있다(W. A. Bowles. F. H. Schneider, L. Lewis, and R. K. Robins, J. Med. Chem., 471(1963)).6-benzyloxypurine was reacted with 2,3-dihydrofuran using p-TsOH acid catalyst to bind, and then benzyl group was removed under Pd-C catalyst to obtain 9- (tetrahydro-2-furyl) hipoxanthin. have. However, this method cannot be used immediately in the presence of -OH or -NH of the purine base, so the process steps are increased and thus the yield is reported to be low (WA Bowles. FH Schneider, L. Lewis, and RK Robins, J.). Med. Chem., 471 (1963).

본 발명은 종래의 공지 방법에서 내포하고 있던 여러 문제점들을 최소화하며, 고수율, 고순도로서 2-푸릴퓨린 유도체를 제조할 수 있으며, 최종 단계에서 목적산물의 분리가 용이한 새로운 제조방법을 제공하고자 하는 것이다. 본 발명자들은 결합시약(촉매)으로서 염화세슘을 사용하여 반응을 수행함으로써 그러한 목적이 성취될 수 있음을 밝혀내었다.The present invention minimizes the problems inherent in the conventional known methods, and can produce 2-furylpurine derivatives in high yield and high purity, and provides a new production method that is easy to separate the target product in the final step. will be. The inventors have found that such an object can be achieved by carrying out the reaction with cesium chloride as the binding reagent (catalyst).

본 발명에 의하여, 다음 일반식(II)의 퓨린 화합물을 트리메틸실릴화한 다음, 염화세슘을 촉매로 사용하여 유기용매 내에서, 일반식(III)의 2-아세톡시테트라히드로푸란과 반응시켜 일반식(I)의 2-푸릴퓨린을 제조하는 방법이 제공된다.According to the present invention, the purine compound of the following general formula (II) is trimethylsilylated, and then reacted with 2-acetoxy tetrahydrofuran of the general formula (III) in an organic solvent using cesium chloride as a catalyst. A method for preparing 2-furylpurine of formula (I) is provided.

Figure kpo00002
Figure kpo00002

Figure kpo00003
Figure kpo00003

일반식(II)에 있어서, X와 Y는 각각 앞서 일반식(I)에서 정의한 바와 같다.In the general formula (II), X and Y are as defined in the general formula (I).

좀더 상세히 설명하면, 일반식(II)의 퓨린 화합물을 실릴화제(바람직하게는 헥사메틸실라제인)와 함께 반응시켜 트리메틸실릴화된 화합물을 산출하고, 결과의 화합물을 유기용매(바람직하게는 아세토니트릴) 내에서 염화세슘 촉매 존재하에 일반식(III)의 2-아세톡시테트라히드로푸란과 반응시켜 일반식(I)의 2-푸릴퓨린 유도체를 제조하는 것이다. 염화세슘은 일반식(II)의 퓨린 화합물에 대하여 몰비로 약 0.1 : 1로 첨가되는 것이 바람직하다.In more detail, the purine compound of formula (II) is reacted with a silylating agent (preferably hexamethylsilase) to yield a trimethylsilylated compound, and the resulting compound is an organic solvent (preferably acetonitrile). And 2-acetyltetrahydrofuran of general formula (III) in the presence of a cesium chloride catalyst to prepare a 2-furylpurine derivative of general formula (I). Cesium chloride is preferably added in a molar ratio of about 0.1: 1 to the Purine Compound of Formula (II).

본 발명의 제조방법은 공지 방법들 보다 반응조건이 온화하고 최종단계에서 목적산물의 분리가 용이하며, 수율이 좋은 것으로 판명되었다. 특히 염화세슘은 공지의 다른 결합시약에 비해서 다루기가 간편하고 회수가 가능하여 2-푸릴퓨린 유도체 제조에 있어서 좋은 결합시약임을 보여 주었다.The production method of the present invention was found to be milder than the known methods, the reaction conditions are easy, the separation of the desired product in the final step, the yield is good. In particular, cesium chloride has been shown to be a good binding reagent in the preparation of 2-furylpurine derivatives because it is easier to handle and recoverable than other known binding reagents.

본 발명의 제조공정을 화학식으로 나타내면 다음과 같다.The manufacturing process of the present invention is represented by the following formula.

Figure kpo00004
Figure kpo00004

Figure kpo00005
Figure kpo00005

Figure kpo00006
Figure kpo00006

다음 실시예는 본 발명을 더욱 상세히 예증하여 줄 것이나 본 발명의 범위가 이에 국한된다는 것은 아니다.The following examples will illustrate the invention in more detail, but the scope of the invention is not limited thereto.

[트리메틸실릴화][Trimethylsilylated]

퓨린 화합물(II, 2mmol)을 헥사메틸디실라제인(HMDS, 10㎖)과 염화암모늄 촉매하에서 120-130℃ 온도에서 환류시킨다. 3-6시간 환류하면 반응용액은 투명한 상태가 되는데 여기서 과량의 HMDS를 감압증류로 회수한 후 실릴화된 화합물은 더 이상의 정제과정 없이 곧바로 다음 반응에 시용한다.Purine compound (II, 2 mmol) was refluxed at 120-130 ° C. under hexamethyldisilazane (HMDS, 10 mL) and ammonium chloride catalyst. After refluxing for 3-6 hours, the reaction solution becomes transparent, where the excess HMDS is recovered by distillation under reduced pressure, and the silylated compound is immediately applied to the next reaction without further purification.

[실시예 1]Example 1

9-(테트라히드로-2-푸릴) 아데닌의 제조Preparation of 9- (tetrahydro-2-furyl) adenine

트리메틸실릴화된 아데닌(2mmol)을 아세토니트릴(5㎖)에 녹이고 염화세슘(35mg, 0.2mmol)과 2-아세톡시테트라히드로푸란(390mg, 3mmol)을 넣은 후, 무수조건에서 5시간동안 상온에서 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(380mg, 92% 수율)을 수득하였다.Trimethylsilylated adenine (2 mmol) was dissolved in acetonitrile (5 mL), cesium chloride (35 mg, 0.2 mmol) and 2-acetoxy tetrahydrofuran (390 mg, 3 mmol) were added, followed by anhydrous conditions at room temperature for 5 hours. Stirred. The reaction mixture was concentrated and then chromatographed to give the desired product (380 mg, 92% yield).

Figure kpo00007
Figure kpo00007

[실시예 2]Example 2

9-(테트라히드로-2-푸릴)-2,6-디아미노퓨린의 제조Preparation of 9- (tetrahydro-2-furyl) -2,6-diaminopurine

트리메틸실릴화된 2,6-디아미노퓨린(2mmol)을 정제 아세토니트릴(5㎖)에 녹인 후 염화세슘(0.2mmol)과 2-아세톡시테트라히드로푸란(3mol)을 넣고 상온에서 약 4시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(440mg, 98% 수율)을 수득하였다.Trimethylsilylated 2,6-diaminopurine (2 mmol) was dissolved in purified acetonitrile (5 mL), followed by adding cesium chloride (0.2 mmol) and 2-acetoxy tetrahydrofuran (3 mol) at room temperature for about 4 hours. Stirred. The reaction mixture was concentrated and then chromatographed to give the desired product (440 mg, 98% yield).

Figure kpo00008
Figure kpo00008

[실시예 3]Example 3

9-(테트라히드로-2-푸릴)-6-클로로퓨린의 제조Preparation of 9- (tetrahydro-2-furyl) -6-chloropurine

트리메틸실릴화한 6-클로로퓨린(2mmol)을 정제 아세토니트릴(5ml)에 녹인 후 염화세슘(0.2mmol)과 2-아세톡시테트라히드로푸란(3mmol)을 넣고 상온에서 약 3시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(428mg, 96% 수율)을 수득하였다.Trimethylsilylated 6-chloropurine (2 mmol) was dissolved in purified acetonitrile (5 ml), cesium chloride (0.2 mmol) and 2-acetoxy tetrahydrofuran (3 mmol) were added, and the mixture was stirred at room temperature for about 3 hours. The reaction mixture was concentrated and then chromatographed to give the desired product (428 mg, 96% yield).

Figure kpo00009
Figure kpo00009

[실시예 4]Example 4

9-(테트라히드로-2-푸릴)-6-메틸티오퓨린의 제조Preparation of 9- (tetrahydro-2-furyl) -6-methylthiopurine

트리메틸실릴화한 6-메틸티오퓨린(2mmol)을 정제 아세토니트릴(5ml)에 녹인 후 염화세슘(0.2mmol)과 2-아세톡시테트라히드로푸란(3mmol)을 넣은 다음, 무수조건 하에서 상온에서 약 1.5시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(331mg, 98% 수율)을 수득하였다.Trimethylsilylated 6-methylthiopurine (2mmol) was dissolved in purified acetonitrile (5ml), cesium chloride (0.2mmol) and 2-acetoxytetrahydrofuran (3mmol) were added, and about 1.5 at room temperature under anhydrous conditions. Stir for hours. The reaction mixture was concentrated and then chromatographed to give the desired product (331 mg, 98% yield).

Figure kpo00010
Figure kpo00010

[실시예 5]Example 5

9-(테트라히드로-2-푸릴)-6-히드록시퓨린의 제조Preparation of 9- (tetrahydro-2-furyl) -6-hydroxypurine

트리메틸실릴화한 히포잔틴(2mmol)을 정제 아세토니트릴(5ml)에 녹인 후 염화세슘(2mmol)과 2-아세톡시테트라히드로푸란(3mmol)을 넣고 상온에서 약 5시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(494mg, 97% 수율)을 수득하였다.Trimethylsilylated hypoxanthine (2 mmol) was dissolved in purified acetonitrile (5 ml), cesium chloride (2 mmol) and 2-acetoxy tetrahydrofuran (3 mmol) were added and stirred at room temperature for about 5 hours. The reaction mixture was concentrated and then chromatographed to give the desired product (494 mg, 97% yield).

Figure kpo00011
Figure kpo00011

[실시예 6]Example 6

9-(테트라히드로-2-푸릴)2-티오아데닌의 제조Preparation of 9- (tetrahydro-2-furyl) 2-thioadenine

트리메틸실릴화된 2-티오-6-아미노퓨린(2mmol)을 정제 아세토니트릴( 5 ml)에 녹인 후 염화세슘(2mmol)과 2-아세톡시테트 라히드 로푸란 (3mmol)을 넣고 상온에서 약 4시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(70% 수율)을 수득하였다.Trimethylsilylated 2-thio-6-aminopurine (2 mmol) was dissolved in purified acetonitrile (5 ml), followed by adding cesium chloride (2 mmol) and 2-acetoxy tetrahydrofuran (3 mmol) at room temperature. Stir for hours. The reaction mixture was concentrated and then chromatographed to give the desired product (70% yield).

Figure kpo00012
Figure kpo00012

[실시예 7]Example 7

9-(테트라히드로-2-푸릴)구아닌의 제조Preparation of 9- (tetrahydro-2-furyl) guanine

트리메틸실릴화된 구아닌(2mmol)과 2-아세톡시테트라히드로푸란(3mmol)을 정제 아세토니트릴(5ml)내에서 상온에서 약 4시간동안 교반하였다. 반응 혼합물을 농축한 후 크로마토그래피를 통하여 목적 생성물(220mg, 50% 수율)을 수득하였다.Trimethylsilylated guanine (2 mmol) and 2-acetoxy tetrahydrofuran (3 mmol) were stirred in purified acetonitrile (5 ml) at room temperature for about 4 hours. The reaction mixture was concentrated and then chromatographed to give the desired product (220 mg, 50% yield).

Figure kpo00013
Figure kpo00013

Claims (4)

일반식(II)의 퓨린 화합물을 트리메틸실릴화한 후 염화세슘 촉매와 유기용매 존재하에 일반식(III)의 2-아세톡시테트라히드로푸란과 반응시키는 것을 특징으로 하는 일반식(I)의 2-푸릴퓨린 유도체의 제조방법.2- of the general formula (I), characterized by reacting the purine compound of the general formula (II) with 2-acetoxytetrahydrofuran of the general formula (III) in the presence of a cesium chloride catalyst and an organic solvent. Method for preparing furylpurine derivatives.
Figure kpo00014
Figure kpo00014
일반식(I)과 (II)에 있어서, X는 -H, -NH2또는 -SH를 나타내며, Y는 -NH2, -Cl, -SMe 또는 -OH를 표시한다.In General Formulas (I) and (II), X represents -H, -NH 2 or -SH, and Y represents -NH 2 , -Cl, -SMe or -OH.
제1항에 있어서, X가 수소이면 Y는 아민, 염소, 메틸티오 또는 히드록시이고; X가 아민이면, Y는 아민이거나 히드록시이고; X가 티올이면 Y가 아민인 것이 특징인, 일반식(I)의 2-푸릴퓨린 유도체의 제조방법.The compound of claim 1, wherein when X is hydrogen, Y is amine, chlorine, methylthio or hydroxy; If X is an amine, Y is an amine or hydroxy; A process for producing a 2-furylpurine derivative of formula (I), wherein X is thiol, Y is amine. 제1항에 있어서, 염화세슘 대 일반식(II)의 퓨린 화합물의 몰비가 0.1 : 1인 것이 특징인, 일반식(I)의 2-푸릴퓨린 유도체의 제조방법.The process for preparing 2-furylpurine derivatives of formula (I) according to claim 1, wherein the molar ratio of cesium chloride to purine compound of formula (II) is 0.1: 1. 제1항 또는 2항에 있어서, 유기용매가 아세토니트릴인 것이 특징인, 일반식(I)의 2-푸릴퓨린 유도체의 제조방법.The process for producing the 2-furylpurine derivative of formula (I) according to claim 1 or 2, wherein the organic solvent is acetonitrile.
KR1019890020246A 1989-12-29 1989-12-29 Process for preparation of 2-furylpurine derivatives KR910009328B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019890020246A KR910009328B1 (en) 1989-12-29 1989-12-29 Process for preparation of 2-furylpurine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019890020246A KR910009328B1 (en) 1989-12-29 1989-12-29 Process for preparation of 2-furylpurine derivatives

Publications (2)

Publication Number Publication Date
KR910011857A KR910011857A (en) 1991-08-07
KR910009328B1 true KR910009328B1 (en) 1991-11-11

Family

ID=19294295

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890020246A KR910009328B1 (en) 1989-12-29 1989-12-29 Process for preparation of 2-furylpurine derivatives

Country Status (1)

Country Link
KR (1) KR910009328B1 (en)

Also Published As

Publication number Publication date
KR910011857A (en) 1991-08-07

Similar Documents

Publication Publication Date Title
AU2010307562B2 (en) Novel method for preparing entecavir and intermediate used therein
US4567254A (en) Method for preparing N6,8-disubstituted 3',5'-cyclic adenosine monophosphate and salt thereof
KR100213936B1 (en) Process for the preparation of 2-amino-6-chloropurine which is a useful intermediate in the preparation of penciclovir or famciclovir
KR910009328B1 (en) Process for preparation of 2-furylpurine derivatives
JPS61227583A (en) Novel chemical process
CN114853648B (en) Method for preparing asymmetric disulfide by NBS (N-bromosuccinimide) to promote breakage of thioether C-S bond
KR910009957B1 (en) Process for preparation of 2-furyl pyrimidine derivatives
JPH0465053B2 (en)
US11203573B2 (en) N-alkylation of acridans
KR910000441B1 (en) Process for the preparation of acyclic purine derivatives
KR900003090B1 (en) Process for preparing aclylic pyrimidine derivatives
KR900007245B1 (en) Process for the preparation of purine derivatives
JPH10130244A (en) Production of acyclonucleoside
CN114478332B (en) Synthesis method of alkyl trifluoromethyl sulfide
JPS5838284A (en) Preparation of 1-(5'-oxohexyl)-3,7-dimethylxanthine
JPS6366176A (en) Production of hydroquinone derivative
JPH10168068A (en) Production of acyclonucleoside
KR100193368B1 (en) Method for preparing riboflavin 5'-phosphate salt
KR100317615B1 (en) A process for the preparation of 8-chloroadenosine 3',5'-cyclic monophosphate
KR820000785B1 (en) Process for preparing 1-(tetrahydro-2-furanyl)-5-fluorouracil
KR900008169B1 (en) Process for prparing acyclic pyrimidine derivatives
JPH0480918B2 (en)
JPH10287657A (en) Production of radiosensitizer
JP3012933B1 (en) Dithianaphthalenophane compound and method for producing the same
KR860001817B1 (en) Process for the preparation of ethyleneimine derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19990630

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee